TFS CAPITAL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 181 filers reported holding HAEMONETICS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2017$1,233,000
+431.5%
30,385
+373.7%
0.40%
+614.3%
Q3 2016$232,000
-77.4%
6,415
-81.9%
0.06%
-70.4%
Q2 2016$1,028,000
-18.5%
35,457
-9.2%
0.19%
+54.9%
Q3 2015$1,262,000
+22.2%
39,048
+56.3%
0.12%
+20.8%
Q2 2015$1,033,000
-67.8%
24,987
-72.5%
0.10%
-60.1%
Q2 2014$3,210,000
+37.2%
90,988
+26.8%
0.25%
+63.2%
Q1 2014$2,339,000
+723.6%
71,780
+908.4%
0.16%
+1092.3%
Q3 2013$284,000
-13.9%
7,118
-10.8%
0.01%
-7.1%
Q2 2013$330,0007,9770.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders